Is NVO up or down today?
NVO is down 8.67% today, last at 47.13. This stock moved -8.67% versus the prior close.
NVO · NVO
NVO (NVO) is trading at 47.13, down 8.67% on the session. Price action shows weakness or stretched conditions worth watching.
Over the past 7 days, 38 headlines skew mixed. Earnings and Macro/Market themes dominated coverage. Stories with measurable price impact averaged -3.73% — headlines dragged the stock.
Social mentions lean cautious or negative.
Analyst firms are mostly reiterating — no strong directional shift lately.
NVO is down 8.67% today, last at 47.13. This stock moved -8.67% versus the prior close.
Over the past 7 days, 38 headlines skew mixed. Earnings and Macro/Market themes dominated coverage. Stories with measurable price impact averaged -3.73% — headlines dragged the stock. Dominant story: Weight Loss Drug Stocks Slump Below Key Levels. What Ozempic Maker Said. (1 source, bearish) RSI is 43 — leaning bearish Price above 50-day average — short-term uptrend Social (demo): 40% of recent mentions lean bullish — social mood is cautious.
Loaded: Feb 2026 – Jul 2026 (125 days) · Drag or scroll left for earlier dates
Analyst firms are mostly reiterating — no strong directional shift lately.
Query: NVO
55/ 100 index
+161.9% vs start of window
Based on 11,347 mentions over 30d
Weight Loss Drug Stocks Slump Below Key Levels. What Ozempic Maker Said.
NVO Stock Plummets as Novo Nordisk Heart Drug Fails Late-Stage Trial - Barchart.com
Novo Nordisk Shares Sink After Heart Disease Drug Candidate Fails Late-Stage Trial
Monte Rosa, BioAge plunge after Novo’s setback (GLUE:NASDAQ) - Seeking Alpha
Monte Rosa, BioAge plunge as Novo’s setback casts a shadow over pipeline